Intrinsiqq
Adaptin Bio, Inc. logo

Adaptin Bio, Inc.

APTN

Compare

Profitability & Returns

Revenue

N/A

Net Income (TTM)

-$5M

▼ -65.5% YoY

Op. Margin

–

ROIC

-3111.13%

▼ -2002.4pp YoY

Cash Flow & Balance Sheet

FCF

N/A

Op. Cash Flow (TTM)

-$3M

▼ -635.9% YoY

Net Debt

-$430K

Net Cash Position

Cash & Equiv.

$430K

Continue Research

SourceComputed from the 10-Q filed 12 Nov 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 14 Nov 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with APTN

CompareIntrinsic value
CLDICalidi Biotherapeutics Inc.
$0.48-5.45%19
INBXInhibrx Biosciences, Inc.
$68.97-7.21%18
CRISCuris Inc.
$0.44-7.21%35
DYAIDyadic International Inc.
$0.29-6.45%25
EXOZExozymes Inc.
$2.91-14.05%10
VIVSVivoSim Labs, Inc.
$0.26-10.34%10
BCDABioCardia, Inc.
$0.79+2.60%26
PLURPluri Inc.
$0.94-3.09%30

Spot a number that looks wrong? Check it in APTN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing APTN

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.